Lumos Pharma, Inc. financial data

Symbol
LUMO on Nasdaq
Industry
Pharmaceutical Preparations
Location
4200 Marathon Blvd., Suite 200, Austin, TX
State of incorporation
DE
Fiscal year end
December 31
Former names
NEWLINK GENETICS CORP (to 3/20/2020)
Latest financial report
10-Q - Q3 2024 - Nov 7, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 462 % -52.8%
Debt-to-equity 79.4 % +211%
Return On Assets -130 % -138%
Operating Margin -1.65K % +19.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.65M shares +9.27%
Common Stock, Shares, Outstanding 8.65M shares +9.27%
Entity Public Float 21.5M USD -53.7%
Weighted Average Number of Shares Outstanding, Basic 8.33M shares +4.38%
Weighted Average Number of Shares Outstanding, Diluted 8.33M shares +4.38%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.21M USD +26.9%
Revenue from Contract with Customer, Excluding Assessed Tax 2.21M USD +26.9%
Research and Development Expense 22.7M USD +11.8%
General and Administrative Expense 15.8M USD -6.13%
Operating Income (Loss) -36.3M USD -2.49%
Nonoperating Income (Expense) 1.41M USD -45.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -7.47M USD +10%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent -34.9M USD -6.37%
Earnings Per Share, Basic -4.28 USD/shares -6.73%
Earnings Per Share, Diluted -4.28 USD/shares -6.73%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 13.5M USD -62%
Cash, Cash Equivalents, and Short-term Investments 36.1M USD -46.4%
Assets, Current 17.3M USD -63.6%
Property, Plant and Equipment, Net 0 USD -100%
Operating Lease, Right-of-Use Asset 187K USD -30.2%
Assets 17.5M USD -63.4%
Accounts Payable, Current 1.46M USD +198%
Employee-related Liabilities, Current 2.9M USD +3.14%
Accrued Liabilities, Current 4.92M USD -10.6%
Liabilities, Current 6.51M USD +6.36%
Operating Lease, Liability, Noncurrent 42K USD -70.6%
Liabilities 12.5M USD +2.35%
Accumulated Other Comprehensive Income (Loss), Net of Tax 0 USD
Retained Earnings (Accumulated Deficit) -187M USD -23%
Stockholders' Equity Attributable to Parent 4.91M USD -86.2%
Liabilities and Equity 17.5M USD -63.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -12.9M USD -40.2%
Net Cash Provided by (Used in) Financing Activities -5K USD +98.4%
Net Cash Provided by (Used in) Investing Activities 1M USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 8.68M shares +9.34%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -11.9M USD +0.59%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 13.5M USD -62%
Deferred Tax Assets, Valuation Allowance 133M USD +9.52%
Deferred Tax Assets, Gross 133M USD +9.52%
Operating Lease, Liability 585K USD +151%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -34.9M USD -6.35%
Lessee, Operating Lease, Liability, to be Paid 652K USD +176%
Operating Lease, Liability, Current 130K USD +3.18%
Lessee, Operating Lease, Liability, to be Paid, Year Two 303K USD
Lessee, Operating Lease, Liability, to be Paid, Year One 332K USD +40.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.1 pure +233%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 67K USD +2133%
Lessee, Operating Lease, Liability, to be Paid, Year Three 17K USD
Deferred Tax Assets, Operating Loss Carryforwards 39M USD +10.8%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Additional Paid in Capital 192M USD +2.32%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2K USD -77.8%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 1.87M USD -21.6%
Interest Expense 0 USD
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%